about
Objective and quantitative assessment of motor function in Parkinson's disease-from the perspective of practical applicationsImpaired trunk stability in individuals at high risk for Parkinson's diseaseRelationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.PREDICT-PD: identifying risk of Parkinson's disease in the community: methods and baseline resultsEnlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly.Idiopathic Parkinson's disease: epidemiology, diagnosis and management.Forced limb-use and recovery following brain injury.Bradykinesia-akinesia incoordination test: validating an online keyboard test of upper limb function"Gunslinger's gait": a new cause of unilaterally reduced arm swing.Protein expression in a Drosophila model of Parkinson's disease.Proteomics in animal models of Alzheimer's and Parkinson's diseases.Identifying prodromal Parkinson's disease: pre-motor disorders in Parkinson's disease.Can stress trigger Parkinson's disease?Apathy and Impulse Control Disorders: Yin & Yang of Dopamine Dependent Behaviors.Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.Transcranial sonography of the substantia nigra: digital image analysis.Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats.Trajectories of prediagnostic functioning in Parkinson's disease.Oxidative stress in Parkinson's disease.Subtle motor disturbances in PREDICT-PD participants.Tachykinins, neurotrophism and neurodegenerative diseases: a critical review on the possible role of tachykinins in the aetiology of CNS diseases.ELECTRONIC PLATFORM MEASURES OF BALANCE IMPAIRMENT IN PARKINSONIANS AND FIRST DEGREE RELATIVES.Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity.Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline.
P2860
Q26751500-579E1508-969E-4871-A3C5-5D6C85981F2FQ28730962-5DDE9B17-C78F-43CE-8200-C06CAC495E12Q30374427-03A2A26B-4062-4BE7-B411-2866D9DEFB2FQ30564071-E0B693CD-FE1F-4A22-A32B-2DCCDD5B9AA9Q33632441-FFDDAB0E-850A-4011-B098-4CF20685AE57Q34053847-051E1230-248C-4EA4-B44C-D9DE2FC9DB10Q35017630-021260FC-A7E0-4F57-89D3-753736E12916Q35159798-FB7A9937-C411-4C71-8355-3CA1BCBDAECAQ36369299-5D25D79C-7E20-4479-B564-9DB2C253CE42Q37002789-4E321BA1-AB8A-44F0-9C48-F6FBB7D61439Q37071539-F1540E72-300A-4FBA-86E9-A591FBBDC666Q38003065-EC1829F6-3D31-42AD-B9F6-8476CA904EEAQ38164648-05D28EA0-38F6-425B-980F-D95553C033EEQ38419501-5D107A8A-221A-4076-A247-94CEDF049911Q38444112-249050AC-1167-4CE9-A32C-55539992EA66Q40210090-60061A31-CC86-4A31-8DEC-7CDEF5FE22C9Q40216082-72F189D5-E885-4EC2-8953-A51D27C77F6FQ40383022-2B904FCE-C6B8-47A6-BA94-BCE92211BF5BQ40538595-0D9161B8-98EA-46F6-A0A9-534BC675D631Q41143619-C0DDF07C-339B-4A14-9F48-B2069E8DFDEFQ41209277-6B827ADE-121B-4330-ABB3-48938F8420BCQ41523572-EF51BD99-CFDE-47FD-8D92-F9BE446545ADQ44686710-C322253E-AF9E-41F3-884C-389F9D778A78Q48599725-477C10BD-0367-4D4C-8F67-D7D6B734D5AC
P2860
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh-hant
name
When did Ray Kennedy's Parkinson's disease begin?
@en
When did Ray Kennedy's Parkinson's disease begin?
@nl
type
label
When did Ray Kennedy's Parkinson's disease begin?
@en
When did Ray Kennedy's Parkinson's disease begin?
@nl
prefLabel
When did Ray Kennedy's Parkinson's disease begin?
@en
When did Ray Kennedy's Parkinson's disease begin?
@nl
P356
P1433
P1476
When did Ray Kennedy's Parkinson's disease begin?
@en
P2860
P304
P356
10.1002/MDS.870070203
P407
P577
1992-01-01T00:00:00Z